Related Experiment Video
Updated: Apr 20, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
[Fatal Panton-Valentine leukocidine-associated Staphylococcus aureus necrotizing pneumonia]
F Laverdure1, C Neulier2, J Sudant3
1Service de réanimation médico-chirurgicale, centre hospitalier de Versailles, site André-Mignot, 177, rue de Versailles, 78150 Le Chesnay, France.
Abstract:
Panton-Valentine leukocidin-producing Staphylococcus aureus necrotizing pneumonia is an unusual cause of community-acquired pneumonia associated with a high fatality rate. The specificities of its presentation must be known by the critical care doctor, in order to quickly make the diagnosis and start the right antibiotics and discuss adjunctive therapy with intravenous immunoglobin. Moreover, the management of close contacts (household and healthcare workers) of patient with such a pneumonia is not well-known. The present case report underlines the clinical presentation of this pneumonia, the specificities of its treatment, and specifies the management of close contacts.
Insights
Panton-Valentine leukocidin-producing Staphylococcus aureus causes severe necrotizing pneumonia with high fatality. Early diagnosis and targeted treatment, including intravenous immunoglobulin and contact management, are crucial for critical care.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Panton-Valentine leukocidin-producing Staphylococcus aureus (PVL-SA) is a rare cause of severe community-acquired pneumonia.
- Necrotizing pneumonia associated with PVL-SA presents a high fatality rate, demanding prompt recognition.
- Optimal management strategies, particularly for close contacts, remain incompletely understood.
Observation:
- This case report details a patient with PVL-SA necrotizing pneumonia.
- The report highlights the unique clinical presentation and diagnostic challenges.
- It also addresses the specific therapeutic interventions employed.
Findings:
- Early diagnosis and appropriate antibiotic selection are critical for patient survival.
- Intravenous immunoglobulin (IVIg) may be considered as an adjunctive therapy.
- Effective management protocols for close contacts are essential to prevent secondary transmission.
Implications:
- Critical care physicians must be aware of PVL-SA necrotizing pneumonia's specific features for timely diagnosis and treatment.
- Understanding the management of close contacts is vital for public health and infection control.
- This case contributes to the knowledge base for managing this severe infectious disease.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
07:27Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
Published on: July 12, 2018
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia
Staphylococcal Skin Infections
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment